Intimation under regulation 30 of SEBI (LODR)Reg, 2015, for Share Purchase Agreement

HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 Date: 23rd September, 2026 BSE Limited Listing Department, Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai – 400 001. Dear Sir / Madam, Subject: Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement Regulations, 2015) Ref: Scrip Code: 524590 | Scrip Symbol: HEMORGANIC | ISIN: INE422G01015 Pursuant to Regulation 30 and Regulation 30A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with Clause 5A of Para A of Part A of Schedule III of the Listing Regulations, we wish to inform you that Mr. Dineshbhai Shanabhai Patel and Mrs. Sonalben Dineshbhai Patel, belonging to the Promoter and Promoter Group of the Company, have entered into separate Share Purchase Agreements (“SPAs”) dated 22nd September, 2026 with the proposed Buyers, as detailed below: Mr. Dineshbhai Shanabhai Patel has entered into a separate share Purchase Agreement with Mrs. Ketanaben Jasani, Mrs. Heema Makadia, M/s. V9BIZ Business Solution LLP and Jasani Family Trust; and Mrs. Sonalben Dineshbhai Patel has entered into a Share Purchase Agreement with Jasani Family Trust, (hereinafter referred to as the “Buyers”), pursuant to which the seller propose to sell, 5,67,958 (Five Lakhs Sixty-Seven Thousand Nine Hundred Fifty-Eight) fully paid-up equity shares representing 16.38% of the Company (8.27% fully diluted shares of the Company assuming full conversion of all outstanding convertible warrants into Equity Shares), subject to the terms and conditions contained in the respective SPAs. The Company is not a party to the SPA and has been apprised of its execution by the concerned parties. The details required under Regulation 30 and Regulation 30A of the Listing Regulations read with SEBI Master Circular dated 30 January 2026, bearing reference no. SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 are enclosed herewith as Annexure A. We request you to take the same on record. Thanking you, FOR, HEMO ORGANIC LIMITED VISHWAMBAR KAMESHWAR SINGH MANAGING DIRECTOR DIN: 09822587 HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 ANNEXURE-A Details required under Regulation 30 and Regulation 30A of the Listing Regulations read with SEBI Master Circular dated 30 January 2026, bearing reference no. SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 Sr. No. Particulars 1. If the listed entity is a party to the Hemo Organic Limited (“Company”) is not a party to the share agreement, purchase agreement. 2. If listed entity is not a party to the i. Mr. Dineshbhai Shanabhai Patel has entered into a separate agreement, share Purchase Agreement with Mrs. Ketanaben Jasani, Mrs. i. name of the party entering into such Heema Makadia, M/s. V9BIZ Business Solution LLP and an agreement and the relationship Jasani Family Trust; and Mrs. Sonalben Dineshbhai Patel has with the listed entity; entered into a Share Purchase Agreement with Jasani Family Trust, pursuant to which the sellers propose to sell, in ii. details of the counterparties to the aggregate, 5,67,958 (Five Lakhs Sixty-Seven Thousand Nine agreement (including name and Hundred Fifty-Eight) fully paid-up equity shares of the relationship with the listed entity); Company, subject to the terms and conditions contained in the respective SPAs. iii. date of entering into the agreement. ii. Details of the counterparties are as follows: (a) Mrs. Ketana Ben Jasani, an individual, proposing to acquire 1,55,986 equity shares representing 4.50% of the existing paid-up equity share capital of the Company and 2.27% of the fully diluted shares of the Company, assuming full conversion of all outstanding convertible warrants into Equity Shares of the Company from Mr. Dineshbhai Shanabhai Patel; and (b) Mrs. Heema Makadia, an individual, proposing to acquire 1,55,986 equity shares representing 4.50% of the existing paid-up equity share capital of the Company and 2.27% of the fully diluted share of the Company, assuming full conversion of all outstanding convertible warrants into Equity Shares of the Company from Mr. Dineshbhai Shanabhai Patel; and (c) V9BIZ Business Solution LLP, (LLPIN: AAZ-4344) proposing to acquire 1,55,986 equity shares representing 4.50% of the existing paid-up equity share capital of the Company and 2.27% of the fully diluted share of the Company, assuming full conversion of all outstanding convertible warrants into Equity Shares of the Company from the Sellers; and (d) Jasani Family Trust, a private trust, proposing to acquire 60,000 equity shares representing 1.73% of the existing paid-up equity share capital of the Company and 0.87% of the fully diluted share of the Company from Mr. Dineshbhai Shanabhai Patel, and 40,000 equity shares representing 1.15% of the existing paid-up equity share capital of the Company and 0.58% of the fully diluted share of the Company from Mrs. Sonalben Dineshbhai Patel, wherein the fully diluted share is calculated assuming full conversion of all outstanding convertible warrants into Equity Shares of the Company; iii. The share purchase agreement (“SPA”) was executed on 22nd September, 2026 HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 3. Purpose of entering into the The SPA records the sale and transfer of 5,67,958 the paid-up agreement equity share capital of the Company by the Sellers to the respective Buyers through an off-market transaction, subject to the terms and conditions contained therein. 4. Shareholding, if any, in the entity Not Applicable with whom the agreement is executed 5. Significant terms of the agreement (i) The Sellers have agreed to sell and transfer, and the (in brief) respective Buyers have agreed to purchase, an aggregate of 5,67,958 (Five Lakhs Sixty-Seven Thousand Nine Hundred Fifty-Eight) fully paid-up equity shares representing 16.38% of the paid-up equity share capital of the Company Company (8.27% fully diluted shares of the Company assuming full conversion of all outstanding convertible warrants into Equity Shares), for such consideration as may be mutually agreed upon by the parties, subject to the terms and conditions set out in the SPA. (ii) The proposed transaction is an off-market transfer of equity shares between the Sellers and the Buyers and is subject to customary representations, warranties, covenants and other terms and conditions as specified in the SPA. (iii) The SPA does not provide for any special rights in favour of the Buyers, including any right to appoint directors, affirmative voting rights, veto rights, pre-emptive rights, first right to subscribe to securities, or any right to restrict changes in the capital structure of the Company. (v) The parties shall undertake such actions and execute such documents as may be necessary for giving effect to the transfer of shares in accordance with applicable laws and the terms of the SPA. 6. Details and quantification of the No, the Company is not party to the agreement. restriction or liability imposed upon the listed entity 7. Whether, the said parties are related Seller is a promoter of the Company. to promoter/promoter group/ group Buyers are not re [Showing first 8,000 characters — download PDF for full document]